Gossamer Bio, Inc. Share Price

Gossamer Bio, Inc. Share Price

NASDAQ: GOSS | Mid Cap
$10.67
-$0.05 (-0.47%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gossamer Bio, Inc. Stock Performance

Open
$10.83
Prev. Close
$10.72
Circuit Range
N/A
Day Range
$10.53 - $10.99
Year Range
$0.11 - $12.46
Volume
2,914
Average Traded
$10.84

Gossamer Bio, Inc. Share Price Today

As of 30 October 2026, Gossamer Bio, Inc.'s share price is $10.67. The stock opened at $10.83, compared to its previous close of $10.72. During today's trading session, Gossamer Bio, Inc.'s share price traded between $10.53 and $10.99, with an average price of $10.76. Over the past 52 weeks, the stock has recorded a high of $12.46 and a low of $0.11. In terms of performance, Gossamer Bio, Inc.'s share price has risen by 2799.46% over the last six months and is up 333.74% on a year-on-year basis.

Gossamer Bio, Inc. Share Price Chart

Line chart of the Gossamer Bio, Inc. price trend over the selected period. The price fell overall, ranging from 10.53 to 11.09, ending at 10.67.
$10.53$10.99
L
Show Current Price
H

Gossamer Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.44B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-20.47
Revenue (TTM)
$48.47B
Return On Equity (TTM)
133.17%
Profit Margin
-351.50%
Debt to Equity
-0.38
Quarterly Earnings Growth YoY
135.05%

Gossamer Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$13.29$13.80$16.96$9.24
Net Profit-$48.22-$47.24-$46.66$16.90
Net Profit Margin-362.83%-342.32%-275.12%182.90%
Income ChangeN/A2.03%1.23%136.22%

Gossamer Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$114.70$48.47
Net Profit-$229.38-$179.82-$56.53-$170.37
Net Profit MarginN/AN/A-49.29%-351.50%
Income ChangeN/A21.61%68.56%-201.38%

About Gossamer Bio, Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Gossamer Bio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.83
$10.69
-10.36%
Sep 2026
$0.17
$11.92
+6,911.76%
Aug 2026
$0.16
$0.17
+1.19%
Jul 2026
$0.16
$0.17
+0.60%
Jun 2026
$0.23
$0.17
-24.77%
May 2026
$0.35
$0.22
-39.67%
Apr 2026
$0.33
$0.37
+11.18%
Mar 2026
$0.41
$0.33
-22.84%
Feb 2026
$2.29
$0.43
-81.10%
Jan 2026
$3.12
$2.27
-27.01%
Dec 2025
$3.24
$3.11
-6.75%
Nov 2025
$2.43
$3.33
+35.57%

GOSS Share Price FAQs